Brace Pharma Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
29
- Portfolio
-
6
- Exits
-
12
Brace Pharma Capital General Information
Company Description
Founded in 2013, Brace Pharma Capital is the corporate venture capital arm of EMS (Pharmaceuticals) based in Atlanta, Georgia. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. The firm prefers to invest in the healthcare, life sciences, and oncology sector firms based in Brazil.
Business Details
Website
www.bracepharma.com/about-usYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 387 Technology Circle NorthWest
- Suite 225
- Atlanta, GA 30313
- United States
Brace Pharma Capital Investments (29)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| F2G | 12-Sep-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Antiva Biosciences | 02-Nov-2021 | Drug Discovery | Generating Revenue | |||
| Turnstone Biologics | 14-Jul-2021 | Biotechnology | Generating Revenue/Not Profitable | |||
| Contineum Therapeutics | 11-Feb-2021 | Drug Discovery | Profitable | |||
| ReViral | 25-Aug-2020 | Drug Discovery | Clinical Trials - Phase 2 | |||
| F2G | 12-Aug-2020 | Drug Discovery | Generating Revenue | |||
| HotSpot Therapeutics | 21-May-2020 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Contineum Therapeutics | 18-Dec-2019 | Drug Discovery | Profitable | |||
| Avidity Biosciences | 13-Nov-2019 | Later Stage VC | Drug Discovery | Generating Revenue/Not Profitable | ||
| F2G | 01-Nov-2019 | Later Stage VC | Drug Discovery | Generating Revenue |
Brace Pharma Capital Exits (12)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Navitor Pharmaceuticals | 25-Oct-2024 | Out of Business | |
| Contineum Therapeutics | 05-Apr-2024 | ||
| Turnstone Biologics | 21-Jul-2023 | ||
| ReViral | 06-Apr-2022 | ||
| Avidity Biosciences | 12-Jun-2020 | ||
| Precision BioSciences | 28-Mar-2019 | ||
| Therabron Therapeutics | 01-Nov-2018 | ||
| AVROBIO | 21-Jun-2018 | ||
| Cogent Biosciences | 29-Mar-2018 | IPO | |
| Zymeworks | 28-Apr-2017 | IPO |
Brace Pharma Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Brace Pharma Capital Co-Investors (54)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Sectoral Asset Management | 2 |
|
|
||
| Sixty Degree Capital |
|
|
|||
| Versant Ventures |
|
|
|||
| Forbion |
|
|
|||
| Northleaf Capital Partners |
|
|
Brace Pharma Capital FAQs
-
What is Brace Pharma Capital?
Founded in 2013, Brace Pharma Capital is the corporate venture capital arm of EMS (Pharmaceuticals) based in Atlanta, Georgia.
-
When was Brace Pharma Capital founded?
Brace Pharma Capital was founded in 2013.
-
Where is Brace Pharma Capital headquartered?
Brace Pharma Capital is headquartered in Atlanta, GA.
-
How many investments has Brace Pharma Capital made?
Brace Pharma Capital has made 29 investments.
-
What has Brace Pharma Capital invested in?
Brace Pharma Capital has made numerous investments in companies like F2G, Antiva Biosciences, and Turnstone Biologics within the Drug Discovery and Biotechnology industries.
-
What has Brace Pharma Capital invested in recently?
Brace Pharma Capital's latest investment was on 12-Sep-2024 in F2G, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
